Nichi-Iko Pharmaceutical Co., Ltd. reported consolidated earnings results for the first quarter ended June 30, 2021. For the quarter, the company reported revenue of ¥42,943 million against ¥45,265 million a year ago. Operating loss was ¥4,124 million against profit of ¥491 million a year ago. Loss was ¥3,881 million against profit of ¥304 million a year ago. Basic loss per share was ¥58.90 against earnings of ¥4.54 a year ago. Diluted loss per share was ¥58.90 against earnings of ¥4.54 a year ago.